Product Code: ETC6185021 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s metered dose inhalers (MDIs) market is well-established, driven by a high prevalence of asthma and chronic obstructive pulmonary disease (COPD). The countrys clean air initiatives and awareness campaigns contribute to early diagnosis and consistent use of inhalers. While traditional MDIs dominate, theres a growing preference for eco-friendly inhaler options in line with sustainability goals.
The metered dose inhalers (MDI) market in Australia is being reshaped by environmental regulations targeting propellants with high global warming potential. This is encouraging the development of greener propellants and alternative inhalation technologies. Patient-friendly designs and digital inhalers that monitor usage are gaining popularity. Additionally, the rise in asthma and COPD cases continues to sustain long-term growth in this market.
The metered dose inhalers (MDI) market in Australia faces several challenges, primarily centered around the accessibility and affordability of inhaler devices. Although MDIs are widely used for treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), they can be expensive, particularly for patients who require long-term use. Additionally, there is concern over the environmental impact of the propellants used in MDIs, which have been linked to ozone depletion. Efforts to transition to more environmentally friendly inhalers face regulatory hurdles and production challenges. Another key challenge is ensuring proper usage of MDIs, as improper technique can lead to reduced effectiveness of the medication, which places an additional burden on healthcare providers to educate patients.
With a strong base of respiratory patients and increasing environmental concerns, there is an opportunity to invest in eco-friendly metered dose inhalers and digital inhaler technologies. Startups developing smart inhalers with adherence-tracking features or green propellant systems are attractive targets. Collaborations with healthcare providers and payers for distribution and clinical trials also present growth avenues.
The Australian government regulates metered dose inhalers (MDIs) through the TGA, ensuring that these devices meet safety and quality standards before they reach consumers. Policies surrounding the PBS ensure that common MDIs are subsidized for patients with conditions like asthma and COPD, making them more affordable. However, government policies are also shifting toward the environmental impact of MDIs, with a growing focus on reducing the use of hydrofluorocarbons (HFCs) as propellants in inhalers. The government has been involved in discussions about transitioning to more environmentally friendly alternatives. Furthermore, policies regarding the accessibility of MDIs for rural and remote areas are also being considered, as patients in these regions may face challenges in obtaining the necessary medications and devices. The government must navigate these environmental, financial, and accessibility concerns while maintaining the availability of effective treatments for respiratory conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Metered Dose Inhalers Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Metered Dose Inhalers Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Metered Dose Inhalers Market - Industry Life Cycle |
3.4 Australia Metered Dose Inhalers Market - Porter's Five Forces |
3.5 Australia Metered Dose Inhalers Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Metered Dose Inhalers Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 Australia Metered Dose Inhalers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Metered Dose Inhalers Market Trends |
6 Australia Metered Dose Inhalers Market, By Types |
6.1 Australia Metered Dose Inhalers Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Metered Dose Inhalers Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Metered Dose Inhalers Market Revenues & Volume, By Manual Actuated, 2021- 2031F |
6.1.4 Australia Metered Dose Inhalers Market Revenues & Volume, By Breath Actuated, 2021- 2031F |
6.2 Australia Metered Dose Inhalers Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Metered Dose Inhalers Market Revenues & Volume, By Asthma, 2021- 2031F |
6.2.3 Australia Metered Dose Inhalers Market Revenues & Volume, By COPD, 2021- 2031F |
6.2.4 Australia Metered Dose Inhalers Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Metered Dose Inhalers Market Import-Export Trade Statistics |
7.1 Australia Metered Dose Inhalers Market Export to Major Countries |
7.2 Australia Metered Dose Inhalers Market Imports from Major Countries |
8 Australia Metered Dose Inhalers Market Key Performance Indicators |
9 Australia Metered Dose Inhalers Market - Opportunity Assessment |
9.1 Australia Metered Dose Inhalers Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Metered Dose Inhalers Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10 Australia Metered Dose Inhalers Market - Competitive Landscape |
10.1 Australia Metered Dose Inhalers Market Revenue Share, By Companies, 2024 |
10.2 Australia Metered Dose Inhalers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |